"Executive Summary Non-Receptor Tyrosine Kinase Inhibitors Market Size, Share, and Competitive Landscape
Global non-receptor tyrosine kinase inhibitors market size was valued at USD 20.34 billion in 2024 and is projected to reach USD 41.32 billion by 2032, with a CAGR of 9.2% during the forecast period of 2025 to 2032.
To attain knowhow of market landscape, brand awareness, latest...
The global subcutaneous immunoglobulin (SCIg) market, valued at USD 11.22 billion in 2024, is anticipated to expand at a CAGR of 9.11% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, administration methods, and therapeutic platforms. The market can be segmented by product type into liquid SCIg, lyophilized SCIg, and ready-to-use prefilled...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek